ErlySign
Nagpur · Founded 2019
About ErlySign
ErlySign develops noninvasive home-based early detection test kits for fatal diseases like Oral cancer, Colorectal cancer, Prostate cancer, Lung Cancer, Breast Cancer, Pancreatic Cancer and many more. With our next generation prognostics & diagnostics solution we can identify the cancer even before a visible tumor or lesion appears. In simple words with our tests we can detect cancer at stage 0.
Company Facts
- Founded: 2019
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $2.2M
- Funding stage: Seed
- Last round: Seed (Jan 2025)
- Website: http://www.erlysign.com
- Phone: +91-9545718785
Industries & Categories
Biotechnology, Health Care, Health Diagnostics, Life Science, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/erlysign-51800 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.